Natural Product: NPC118459

Natural Product IDNPC118459
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Norvaline
IUPAC Name (2S)-2-azaniumylpentanoate
Synonyms 2-Amino-Pentanoic Acid; L-Norvaline
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL55612
PubChem CID 6950514
65098
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000347] Amino acids and derivatives
            • [CHEMONTID:0000060] Alpha amino acids and derivatives
              • [CHEMONTID:0002404] Alpha amino acids
                • [CHEMONTID:0004146] L-alpha-amino acids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SNDPXSYFESPGGJ-BYPYZUCNSA-N
Standard InCHI InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
SMILES CCC[C@@H](C(=O)O)N

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   117.08 Volume:   120.977
?
Van der Waals volume.
Dense:   0.968 LogP:   -1.824
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -0.292
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   0.153
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   1.0
TPSA:   63.32
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   3.0 Rings:   0.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.555 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.391 Fsp3:   0.8
MCE-18:   2.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.601 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.014
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.003
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.899 Promiscuous compounds:   0.96

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.739 MDCK Permeability:   -4.418
Pgp-inhibitor:   0.0 Pgp-substrate:   0.054
PAMPA:   0.976
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.001 30% Bioavailability (F30%):   0.0
50% Bioavailability (F50%):   0.025

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.01 MRP1:   0.668
Plasma Protein Binding (PPB):   24.8% Volume Distribution (VD):   -0.087
Fu: 75.04%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.676
OATP1B3 inhibitor:   0.904 BCRP inhibitor:   0.0
BSEP inhibitor:   0.02

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.024 CYP2C9-substrate:   0.002
CYP2D6-inhibitor:   0.997 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.013
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.269
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  7.332 Half-life (T1/2):  1.061

ADMET: Toxicity

hERG Blockers:  0.066 hERG Blockers (10um):  0.247
Human Hepatotoxicity (H-HT):  0.536 Drug-induced Liver Injury (DILI):  0.076
AMES Toxicity:  0.407 Rat Oral Acute Toxicity:  0.458
Maximum Recommended Daily Dose:  0.08 Skin Sensitization:  0.785
Carcinogencity:  0.32 Eye Corrosion:  0.909
Eye Irritation:  0.962 Respiratory Toxicity:  0.657
Drug-induced Neurotoxicity:  0.398 Ototoxicity:  0.172
Hematotoxicity:  0.227 Drug-induced Nephrotoxicity:  0.664
Genotoxicity:  0.155 RPMI-8226 Immunitoxicity:  0.063
A549 Cytotoxicity:  0.022 Hek293 Cytotoxicity:  0.033
BCF:   0.257
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.763
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   3.823
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.172
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2567 Serratia marcescens Species Yersiniaceae Bacteria n.a. n.a. n.a. PMID[14325279]
NPO2567 Serratia marcescens Species Yersiniaceae Bacteria n.a. n.a. n.a. PMID[15853884]
NPO2567 Serratia marcescens Species Yersiniaceae Bacteria n.a. n.a. n.a. PMID[18313305]
NPO2567 Serratia marcescens Species Yersiniaceae Bacteria n.a. n.a. n.a. PMID[783153]
NPO2567 Serratia marcescens Species Yersiniaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO2567 Serratia marcescens Species Yersiniaceae Bacteria n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1006 Individual protein Proton-coupled amino acid transporter 1 Homo sapiens Ki = 46000000.0 nM PMID[21955456]
NPT1006 Individual protein Proton-coupled amino acid transporter 1 Homo sapiens pKi = -1.66 mM PMID[21955456]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC118459 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC327698
1.0 High Similarity NPC53449
0.7778 Intermediate Similarity NPC63621
0.7778 Intermediate Similarity NPC326992
0.7778 Intermediate Similarity NPC121517
0.7778 Intermediate Similarity NPC168375
0.7778 Intermediate Similarity NPC600066
0.7619 Intermediate Similarity NPC167986
0.7619 Intermediate Similarity NPC291186
0.7059 Intermediate Similarity NPC116709
0.7059 Intermediate Similarity NPC21290
0.7059 Intermediate Similarity NPC272614
0.6667 Remote Similarity NPC245027
0.6667 Remote Similarity NPC162620
0.6667 Remote Similarity NPC62045
0.6667 Remote Similarity NPC601942
0.625 Remote Similarity NPC102815
0.619 Remote Similarity NPC329263
0.619 Remote Similarity NPC309658
0.619 Remote Similarity NPC604272
0.619 Remote Similarity NPC607953
0.6087 Remote Similarity NPC140872
0.6087 Remote Similarity NPC93081
0.6 Remote Similarity NPC132307
0.6 Remote Similarity NPC126925
0.5909 Remote Similarity NPC84636
0.5909 Remote Similarity NPC226027
0.5909 Remote Similarity NPC174246
0.5909 Remote Similarity NPC43204
0.5833 Remote Similarity NPC608987
0.5652 Remote Similarity NPC49952
0.5652 Remote Similarity NPC153370
0.5652 Remote Similarity NPC34908
0.5652 Remote Similarity NPC136476
0.56 Remote Similarity NPC279661
0.56 Remote Similarity NPC183845
0.56 Remote Similarity NPC324825
0.56 Remote Similarity NPC112890
0.56 Remote Similarity NPC316231
0.55 Remote Similarity NPC237525
0.55 Remote Similarity NPC326212
0.5455 Remote Similarity NPC270805
0.5455 Remote Similarity NPC93888
0.5417 Remote Similarity NPC137958
0.5417 Remote Similarity NPC273330
0.5417 Remote Similarity NPC600338
0.5385 Remote Similarity NPC190184
0.5385 Remote Similarity NPC197087
0.5263 Remote Similarity NPC9294
0.5238 Remote Similarity NPC198301
0.52 Remote Similarity NPC322532
0.52 Remote Similarity NPC50047
0.5185 Remote Similarity NPC602488
0.5172 Remote Similarity NPC38463

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC118459 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7619 Intermediate Similarity NPD8804 Phase 4
0.7619 Intermediate Similarity NPD8805 Approved
0.7619 Intermediate Similarity NPD9016 Phase 1
0.7059 Intermediate Similarity NPD8210 Phase 3
0.7059 Intermediate Similarity NPD8211 Approved
0.6667 Remote Similarity NPD9018 Phase 3
0.6522 Remote Similarity NPD9021 Pre-clinical
0.6087 Remote Similarity NPD8809 Phase 3
0.6 Remote Similarity NPD8798 Phase 2
0.5909 Remote Similarity NPD9017 Phase 2
0.5652 Remote Similarity NPD8614 Pre-clinical
0.56 Remote Similarity NPD9044 Phase 4
0.5455 Remote Similarity NPD8624 Phase 2
0.5455 Remote Similarity NPD8801 Phase 4
0.5417 Remote Similarity NPD8872 Phase 3
0.5385 Remote Similarity NPD8785 Phase 4
0.52 Remote Similarity NPD8871 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data